AAPL338.05+8.65 (+2.63%) ▲|ABBV263.40+0.11 (+0.04%) ▲|ABT99.66-1.30 (-1.28%) ▼|ACN181.27+4.15 (+2.34%) ▲|ADBE237.26+4.09 (+1.75%) ▲|AMAT511.23-0.78 (-0.15%) ▼|AMD603.34-4.23 (-0.70%) ▼|AMGN423.83+0.19 (+0.04%) ▲|AMT165.47-0.09 (-0.05%) ▼|AMZN247.35+0.68 (+0.28%) ▲|AVGO355.20+0.10 (+0.03%) ▲|AXP304.75-0.66 (-0.21%) ▼|BA188.24+0.56 (+0.30%) ▲|BAC54.87-0.09 (-0.16%) ▼|BKNG162.92+0.58 (+0.36%) ▲|BLK1,068.90+0.96 (+0.09%) ▲|BMY63.58+0.72 (+1.15%) ▲|BNY147.10+0.12 (+0.08%) ▲|BRK-B500.40-1.95 (-0.39%) ▼|C130.70-0.11 (-0.08%) ▼|CAT821.74-4.91 (-0.59%) ▼|CL86.64+0.18 (+0.21%) ▲|CMCSA21.83+0.23 (+1.04%) ▲|COF195.76-0.70 (-0.36%) ▼|COP126.08+0.64 (+0.51%) ▲|COST921.00-3.59 (-0.39%) ▼|CRM231.32+6.01 (+2.67%) ▲|CSCO107.67+0.73 (+0.68%) ▲|CVS86.40-0.71 (-0.81%) ▼|CVX205.40+1.02 (+0.50%) ▲|DE681.26+2.38 (+0.35%) ▲|DHR224.88-0.83 (-0.37%) ▼|DIS106.23+0.82 (+0.77%) ▲|DUK114.79+0.58 (+0.51%) ▲|EMR158.05+0.81 (+0.52%) ▲|FDX287.21-0.26 (-0.09%) ▼|GD332.24-0.10 (-0.03%) ▼|GE313.55-4.57 (-1.44%) ▼|GEV965.96+3.25 (+0.34%) ▲|GILD150.21-1.08 (-0.71%) ▼|GM79.39-1.10 (-1.36%) ▼|GOOG344.75+7.43 (+2.20%) ▲|GOOGL348.43+7.51 (+2.20%) ▲|GS911.00-5.37 (-0.59%) ▼|HD287.09-1.09 (-0.38%) ▼|HON210.42+0.29 (+0.14%) ▲|IBM221.17+1.16 (+0.53%) ▲|INTC117.89+1.96 (+1.69%) ▲|INTU273.47+5.44 (+2.03%) ▲|ISRG409.71-2.47 (-0.60%) ▼|JNJ266.62-1.04 (-0.39%) ▼|JPM335.46+0.42 (+0.13%) ▲|KO87.24+0.38 (+0.44%) ▲|LIN478.44+5.07 (+1.07%) ▲|LLY1,188.88+3.12 (+0.26%) ▲|LMT505.96-6.18 (-1.21%) ▼|LOW186.36-0.86 (-0.46%) ▼|LRCX324.75+0.89 (+0.27%) ▲|MA556.81-6.85 (-1.22%) ▼|MCD233.25-0.80 (-0.34%) ▼|MDLZ58.95+0.15 (+0.26%) ▲|MDT86.56-0.55 (-0.63%) ▼|META731.70-7.09 (-0.96%) ▼|MMM168.59+0.14 (+0.08%) ▲|MO68.33-0.39 (-0.56%) ▼|MRK148.43-0.90 (-0.60%) ▼|MS191.32-1.53 (-0.79%) ▼|MSFT516.33+7.37 (+1.45%) ▲|MU1,067.68+2.60 (+0.24%) ▲|NEE75.93+0.04 (+0.05%) ▲|NFLX69.70-0.60 (-0.85%) ▼|NKE35.70-0.14 (-0.39%) ▼|NOW132.91+2.92 (+2.24%) ▲|NVDA230.85+3.64 (+1.60%) ▲|ORCL136.39-1.51 (-1.09%) ▼|PEP129.33+0.64 (+0.49%) ▲|PFE28.67-0.06 (-0.19%) ▼|PG148.06-0.30 (-0.20%) ▼|PLTR189.84+2.87 (+1.54%) ▲|PM193.30-0.67 (-0.34%) ▼|QCOM185.97+1.87 (+1.01%) ▲|RTX185.77-1.28 (-0.68%) ▼|SBUX95.44+0.01 (+0.01%) ▲|SCHW98.49-0.62 (-0.62%) ▼|SO83.47+0.02 (+0.02%) ▲|SPG202.21-2.07 (-1.01%) ▼|T24.50+0.02 (+0.08%) ▲|TMO677.39-2.26 (-0.33%) ▼|TMUS163.74+0.76 (+0.47%) ▲|TSLA346.72-6.12 (-1.73%) ▼|TXN281.88+0.19 (+0.07%) ▲|UBER68.95-0.41 (-0.59%) ▼|UNH366.33-8.61 (-2.30%) ▼|UNP276.01+1.86 (+0.68%) ▲|UPS93.70-0.24 (-0.25%) ▼|USB57.76+0.16 (+0.28%) ▲|V361.55-4.33 (-1.18%) ▼|VZ45.78-0.20 (-0.44%) ▼|WFC80.39-0.09 (-0.11%) ▼|WMT106.36-0.44 (-0.41%) ▼|XOM162.78+1.43 (+0.89%) ▲|AAPL338.05+8.65 (+2.63%) ▲|ABBV263.40+0.11 (+0.04%) ▲|ABT99.66-1.30 (-1.28%) ▼|ACN181.27+4.15 (+2.34%) ▲|ADBE237.26+4.09 (+1.75%) ▲|AMAT511.23-0.78 (-0.15%) ▼|AMD603.34-4.23 (-0.70%) ▼|AMGN423.83+0.19 (+0.04%) ▲|AMT165.47-0.09 (-0.05%) ▼|AMZN247.35+0.68 (+0.28%) ▲|AVGO355.20+0.10 (+0.03%) ▲|AXP304.75-0.66 (-0.21%) ▼|BA188.24+0.56 (+0.30%) ▲|BAC54.87-0.09 (-0.16%) ▼|BKNG162.92+0.58 (+0.36%) ▲|BLK1,068.90+0.96 (+0.09%) ▲|BMY63.58+0.72 (+1.15%) ▲|BNY147.10+0.12 (+0.08%) ▲|BRK-B500.40-1.95 (-0.39%) ▼|C130.70-0.11 (-0.08%) ▼|CAT821.74-4.91 (-0.59%) ▼|CL86.64+0.18 (+0.21%) ▲|CMCSA21.83+0.23 (+1.04%) ▲|COF195.76-0.70 (-0.36%) ▼|COP126.08+0.64 (+0.51%) ▲|COST921.00-3.59 (-0.39%) ▼|CRM231.32+6.01 (+2.67%) ▲|CSCO107.67+0.73 (+0.68%) ▲|CVS86.40-0.71 (-0.81%) ▼|CVX205.40+1.02 (+0.50%) ▲|DE681.26+2.38 (+0.35%) ▲|DHR224.88-0.83 (-0.37%) ▼|DIS106.23+0.82 (+0.77%) ▲|DUK114.79+0.58 (+0.51%) ▲|EMR158.05+0.81 (+0.52%) ▲|FDX287.21-0.26 (-0.09%) ▼|GD332.24-0.10 (-0.03%) ▼|GE313.55-4.57 (-1.44%) ▼|GEV965.96+3.25 (+0.34%) ▲|GILD150.21-1.08 (-0.71%) ▼|GM79.39-1.10 (-1.36%) ▼|GOOG344.75+7.43 (+2.20%) ▲|GOOGL348.43+7.51 (+2.20%) ▲|GS911.00-5.37 (-0.59%) ▼|HD287.09-1.09 (-0.38%) ▼|HON210.42+0.29 (+0.14%) ▲|IBM221.17+1.16 (+0.53%) ▲|INTC117.89+1.96 (+1.69%) ▲|INTU273.47+5.44 (+2.03%) ▲|ISRG409.71-2.47 (-0.60%) ▼|JNJ266.62-1.04 (-0.39%) ▼|JPM335.46+0.42 (+0.13%) ▲|KO87.24+0.38 (+0.44%) ▲|LIN478.44+5.07 (+1.07%) ▲|LLY1,188.88+3.12 (+0.26%) ▲|LMT505.96-6.18 (-1.21%) ▼|LOW186.36-0.86 (-0.46%) ▼|LRCX324.75+0.89 (+0.27%) ▲|MA556.81-6.85 (-1.22%) ▼|MCD233.25-0.80 (-0.34%) ▼|MDLZ58.95+0.15 (+0.26%) ▲|MDT86.56-0.55 (-0.63%) ▼|META731.70-7.09 (-0.96%) ▼|MMM168.59+0.14 (+0.08%) ▲|MO68.33-0.39 (-0.56%) ▼|MRK148.43-0.90 (-0.60%) ▼|MS191.32-1.53 (-0.79%) ▼|MSFT516.33+7.37 (+1.45%) ▲|MU1,067.68+2.60 (+0.24%) ▲|NEE75.93+0.04 (+0.05%) ▲|NFLX69.70-0.60 (-0.85%) ▼|NKE35.70-0.14 (-0.39%) ▼|NOW132.91+2.92 (+2.24%) ▲|NVDA230.85+3.64 (+1.60%) ▲|ORCL136.39-1.51 (-1.09%) ▼|PEP129.33+0.64 (+0.49%) ▲|PFE28.67-0.06 (-0.19%) ▼|PG148.06-0.30 (-0.20%) ▼|PLTR189.84+2.87 (+1.54%) ▲|PM193.30-0.67 (-0.34%) ▼|QCOM185.97+1.87 (+1.01%) ▲|RTX185.77-1.28 (-0.68%) ▼|SBUX95.44+0.01 (+0.01%) ▲|SCHW98.49-0.62 (-0.62%) ▼|SO83.47+0.02 (+0.02%) ▲|SPG202.21-2.07 (-1.01%) ▼|T24.50+0.02 (+0.08%) ▲|TMO677.39-2.26 (-0.33%) ▼|TMUS163.74+0.76 (+0.47%) ▲|TSLA346.72-6.12 (-1.73%) ▼|TXN281.88+0.19 (+0.07%) ▲|UBER68.95-0.41 (-0.59%) ▼|UNH366.33-8.61 (-2.30%) ▼|UNP276.01+1.86 (+0.68%) ▲|UPS93.70-0.24 (-0.25%) ▼|USB57.76+0.16 (+0.28%) ▲|V361.55-4.33 (-1.18%) ▼|VZ45.78-0.20 (-0.44%) ▼|WFC80.39-0.09 (-0.11%) ▼|WMT106.36-0.44 (-0.41%) ▼|XOM162.78+1.43 (+0.89%) ▲|
21.2 C
New York
Wednesday, September 30, 2026

Tag: 1

newssourceFORcompanyinformationcontent1releasesmarket

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Red Cat Holdings, Inc. (RCAT) Investors with Substantial Losses Have Opportunity to Lead Investor...

SAN DIEGO, June 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ: RCAT) securities between March 18, 2022 and January 15, 2025, inclusive (the “Class Period”), have until Tuesday, July 22, 2025 to seek appointment as lead plaintiff of the Red Cat class action lawsuit. Captioned Olsen v. Red Cat Holdings, Inc., No. 25-cv-05427 (D.N.J.), the Red Cat class action lawsuit charges Red Cat as well as certain of Red Cat’s top current and former executives with violations of the Securities Exchange Act of 1934.

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline.

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations that GeneDx may have issued materially misleading business information to the investing public.

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Krispy Kreme, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DNUT

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Krispy Kreme, Inc. (NASDAQ: DNUT) between February 25, 2025 and May 7, 2025, both dates inclusive (the “Class Period”), of the important July 15, 2025 lead plaintiff deadline.

Pizza 73 Celebrates the Heart of Oil Country with Free Heart Pizzas for Fans

EDMONTON, AB, June 22, 2025 /CNW/ - Pizza 73, the beloved Alberta-born pizza chain and official pizza partner of the Edmonton Oilers, is celebrating Oilers...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DV

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the “Class Period”), of the important July 21, 2025 lead plaintiff deadline.

NSSC DEADLINE TUESDAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important June 24 Deadline in Securities Class...

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline.

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea Holdings, Inc. ("Fortrea" or the...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation – DDD

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation ("3D Systems" or the...

Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company")...

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published...

Bagsværd, Denmark, 22 June – Today, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3 REDEFINE 1 trial evaluating the efficacy and safety of investigational CagriSema plus lifestyle interventions for weight loss in adults with obesity or overweight who have a weight-related medical complication and without diabetes.1 REDEFINE 1 met its co-primary endpoints and achieved statistically significant and clinically meaningful weight loss at 68 weeks in patients taking CagriSema versus placebo.1 These data, along with the related phase 3 REDEFINE 2 study conducted in adults with overweight or obesity and type 2 diabetes, were presented today during a scientific symposium at the American Diabetes Association’s (ADA) 85th Scientific Sessions and published in NEJM.

CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM

Data presented simultaneously at the American Diabetes Association's® 85th Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing...

CagriSema Demonstrates Significant Weight Loss in Adults with Obesity

Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes CHICAGO, June 22,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers